• circ_0042103/TAF15/NER Axis Links Circular RNA to DNA Damage

  2026-05-04

  This study uncovers a novel circ_0042103/TAF15/NER regulatory axis driving DNA damage and inflammation in dental pulpitis. By mechanistically connecting circular RNA regulation with impaired DNA repair, the work advances our understanding of inflammatory disease progression and highlights new molecular targets for tissue regeneration.

• Oligo (dT) 25 Beads: Technical Guidance for mRNA Isolation

  2026-05-04

  Oligo (dT) 25 Beads address the need for rapid, highly specific eukaryotic mRNA isolation by leveraging magnetic bead-based polyA tail capture. They are best suited for workflows requiring intact mRNA for downstream applications such as RT-PCR and next-generation sequencing. These beads are not recommended when non-polyadenylated RNA species are required or for workflows incompatible with magnetic separation.

• PA-824: Bicyclic Nitroimidazole Derivative in TB Research

  2026-05-03

  PA-824 empowers anti-tuberculosis research with its potent, dual-action mechanism and high-purity formulation, enabling reproducible inhibition of both drug-sensitive and drug-resistant Mycobacterium tuberculosis strains. This article details experimental workflows, advanced use-cases, and troubleshooting strategies that maximize the translational impact of this trusted APExBIO compound.

• Aneugen Mechanism Assay: Molecular Targets and Microtubule D

  2026-05-02

  This article reviews a proof-of-concept bioassay that differentiates aneugenic mechanisms by analyzing the effects of 27 chemicals, including microtubule-associated inhibitors, on mammalian cell models. The work advances the field by coupling flow cytometry with machine learning to resolve tubulin-specific actions from mitotic kinase inhibition, providing a robust framework for mechanistic genotoxicity assessment.

• Erastin as a Ferroptosis Inducer: Protocols and Research Imp

  2026-05-01

  Erastin stands out as a precision ferroptosis inducer, enabling researchers to dissect oxidative cell death pathways in RAS- and BRAF-mutant tumor models. This article delivers workflow guidance, troubleshooting tips, and translational insights grounded in recent ferroptosis research.

• Bestatin Stimulates Endothelial Invasion in Fibrin Matrices

  2026-05-01

  This study reveals that Bestatin (Ubenimex), an aminopeptidase inhibitor, unexpectedly enhances microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. The findings challenge prevailing assumptions about Bestatin’s anti-angiogenic roles and highlight the complexity of aminopeptidase function in tumor microenvironments.

• Canagliflozin Reshapes Mitochondria in Diabetic Kidney Disea

  2026-04-30

  Trentin-Sonoda et al. reveal that canagliflozin, a selective SGLT2 inhibitor, not only lowers glucose but also remodels mitochondrial structure and enhances bioenergetic function in proximal tubular cells of hypertensive–diabetic mice. These findings suggest a mechanism of renal protection that extends beyond glycemic control, prompting new directions for diabetes and kidney disease research.

• Imipenem: Advanced Mechanistic Insights for Immune Modulatio

  2026-04-30

  Explore Imipenem, a semisynthetic thienamycin antibiotic, through the lens of its unique immunomodulatory mechanisms, stability, and strategic utility in antibacterial research. This article delivers novel perspectives on immune response modulation and assay decision-making, grounded in recent scientific advances.

• Sitagliptin Phosphate Monohydrate: Advanced DPP-4 Inhibitor

  2026-04-29

  Leverage Sitagliptin phosphate monohydrate for precise DPP-4 inhibition and robust incretin hormone modulation in metabolic, stem cell, and atherosclerosis models. This article delivers actionable protocols, troubleshooting strategies, and translational insights, linking bench research with emerging findings in satiety and glucose regulation.

• Sequencing Therapies in Waldenström Macroglobulinemia: Genom

  2026-04-29

  This review dissects the evolving framework for sequencing therapies in Waldenström macroglobulinemia (WM), highlighting the crucial role of MYD88 and CXCR4 mutations in guiding treatment selection. The reference paper emphasizes genomic profiling, emerging targeted agents—including CXCR4 antagonists—and the nuanced considerations for optimizing patient outcomes.

• Hexetidine (NSC-17764): Optimizing Biofilm and Oral Infectio

  2026-04-28

  Hexetidine (NSC-17764) empowers translational and bench scientists to tackle oral biofilm, dental plaque, and fungal infections with broad-spectrum precision. This article details advanced assay workflows, troubleshooting tactics, and key evidence, positioning APExBIO’s Hexetidine as a pivotal tool in oral antimicrobial research.

• HyperScript™ Reverse Transcriptase: Reliable cDNA Synthesis

  2026-04-28

  This article explores real laboratory scenarios where reverse transcription of complex or low-abundance RNA is critical, highlighting how HyperScript™ Reverse Transcriptase (SKU K1071) addresses common pain points in cDNA synthesis for qPCR and cytotoxicity assays. Using evidence-backed analysis and practical guidance, it demonstrates the enzyme’s strengths in sensitivity, thermal stability, and workflow reproducibility for biomedical researchers.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Dr

  2026-04-27

  A recent study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal subpopulations, closely replicating the tumor microenvironment. This innovation enables deeper exploration of cell–cell interactions, gene expression, and drug response variability, advancing research into resistance mechanisms and personalized therapy.

• Griseofulvin: Precision Microtubule Inhibition in Antifungal

  2026-04-27

  In this thought-leadership article, we explore how Griseofulvin—a lab-grade microtubule associated inhibitor—empowers translational researchers to both dissect the mechanistic underpinnings of fungal cell mitosis inhibition and advance antifungal drug research. Drawing on recent advances in molecular mechanism assays and cross-validated workflows, we provide actionable guidance for protocol optimization, critically appraise current competitive landscapes, and offer a forward-looking perspective on the role of precise microtubule disruption in next-generation antifungal discovery.

• Coronavirus Macrodomains Counteract PARP-Mediated Antiviral

  2026-04-26

  This study demonstrates the essential role of the coronavirus macrodomain in antagonizing PARP-mediated inhibition of viral replication and enhancing interferon (IFN) expression. By dissecting the interplay between viral macrodomains and host poly (ADP-ribose) polymerases, particularly PARP12 and PARP14, the research reveals mechanistic insights relevant for both antiviral strategy development and the use of PARP inhibitors in experimental virology.

15751 records 4/1051 page Previous Next 12345 下5页 Last page